Cargando…

MF management

Detalles Bibliográficos
Autores principales:	Bose, Prithviraj, Verstovsek, Srdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Myeloproliferative neoplasms - Section 15
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925717/ https://www.ncbi.nlm.nih.gov/pubmed/35309812 http://dx.doi.org/10.1097/HS9.0000000000000210

Ejemplares similares

Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
por: Nangalia, Jyoti
Publicado: (2019)

Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
por: Gleitz, Hélène F.E., et al.
Publicado: (2019)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study
por: Dwabe, Sami, et al.
Publicado: (2021)

Biology and therapeutic targeting of molecular mechanisms in MPNs
por: How, Joan, et al.
Publicado: (2023)

JAK2(V617F) allele burden in polycythemia vera: burden of proof
por: Moliterno, Alison R., et al.
Publicado: (2023)

Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023)

Myelofibrosis
por: Passamonti, Francesco, et al.
Publicado: (2023)

Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic
por: Barbui, Tiziano, et al.
Publicado: (2021)

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
por: Mora, Barbara, et al.
Publicado: (2022)

Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
por: Verstovsek, Srdan, et al.
Publicado: (2021)

Updates in the management of polycythemia vera and essential thrombocythemia
por: Bose, Prithviraj, et al.
Publicado: (2019)

Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
por: Yacoub, A., et al.
Publicado: (2014)

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
por: Verstovsek, Srdan, et al.
Publicado: (2023)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future Perspectives
por: Bose, Prithviraj, et al.
Publicado: (2020)

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms
por: Bose, Prithviraj, et al.
Publicado: (2020)

Momelotinib: an emerging treatment for myelofibrosis patients with anemia
por: Chifotides, Helen T., et al.
Publicado: (2022)

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments
por: Chifotides, Helen T., et al.
Publicado: (2023)

Cancer, an introduction /
por: Creasey, William A.
Publicado: (1981)

Posterior Reversible Encephalopathy Syndrome in ALL
por: Millichap, J. Gordon
Publicado: (2015)

The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology
por: Perchiazzi, Gaetano, et al.
Publicado: (2020)

Recommendations for developing clinical care protocols during pandemics: From theory and practice
por: Waterman, Ruth S., et al.
Publicado: (2021)

Transnasal Videoendoscopy for Preoperative Airway Risk Stratification: Development and Validation of a Multivariable Risk Prediction Model
por: Barclay-Steuart, Alexander, et al.
Publicado: (2023)

Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms
por: Trikalinos, Nikolaos A., et al.
Publicado: (2022)

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
por: Mei, Matthew, et al.
Publicado: (2022)

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
por: Murthy, Guru Subramanian Guru, et al.
Publicado: (2023)

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms
por: Shi, Zhongxun, et al.
Publicado: (2022)

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
por: Jain, Tania, et al.
Publicado: (2023)

S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY
por: Gerds, Aaron T., et al.
Publicado: (2023)

Age‐related macular degeneration and myeloproliferative neoplasms – A common pathway
por: Liisborg, Charlotte
Publicado: (2022)

Coupling patient care management operations with technology and data platform to optimize hepatitis C therapy outcomes
por: Duong, Lily, et al.
Publicado: (2019)

Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
por: Alhuraiji, Ahmad, et al.
Publicado: (2017)

How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?
por: Niederle, Bruno, et al.
Publicado: (2021)

Imaging in cervical nodal metastases of unknown primary
por: Hermans, Robert
Publicado: (2011)

Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
por: Francis, Isaac R.
Publicado: (2007)

Imaging of anterior mediastinal masses
por: Quint, Leslie E.
Publicado: (2007)

Biliary tract neoplasms: diagnosis and staging
por: Gore, Richard M., et al.
Publicado: (2007)

The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
por: Birgegård, Gunnar
Publicado: (2016)

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
por: Bhatnagar, Neha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k0nhf3pbukcil6lljvviomrf3o